BETH RANKIN: Open Payments
NPI 1316085277 · ALLISON PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 30 payments from 11 companies in 2025. Trend: 2023 $830 · 2024 $639 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $158 |
| UCB, Inc. | 4 | $112 |
| Lilly USA, LLC | 3 | $60 |
| TOLMAR, INC. | 2 | $52 |
| Organon LLC | 2 | $28 |
| GENZYME CORPORATION | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
Products named: Bimzelx, SKYRIZI, RINVOQ, JATENZO, TALTZ, DUPIXENT, VTAMA, YCANTH.
Industry payments across PA — which companies pay providers there.
